Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.66% | -41.60% | -35.64% | -31.31% | -15.80% |
| Total Depreciation and Amortization | 18.96% | 17.56% | 18.42% | 14.76% | 3.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -190.38% | -134.98% | -86.35% | 451.11% | 23,804.35% |
| Change in Net Operating Assets | 267.07% | 189.42% | 218.46% | 567.60% | -11.29% |
| Cash from Operations | -23.18% | -27.08% | -29.68% | -16.76% | -11.28% |
| Capital Expenditure | 9.96% | 64.28% | 40.77% | 30.19% | -404.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 220.09% | 11,590.16% | 11,590.16% | -150.46% | -231.58% |
| Cash from Investing | 178.03% | 124.06% | 99.05% | -201.02% | -248.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 49.84% | -31.25% | -31.25% | 79.63% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -93.92% | -8.85% | -7.31% | -37.22% | -- |
| Cash from Financing | 49.00% | -27.79% | -27.64% | 62.74% | -- |
| Foreign Exchange rate Adjustments | 2,492.51% | -18.67% | -76.67% | -96.01% | -102.04% |
| Miscellaneous Cash Flow Adjustments | -- | -- | 100.00% | 100.00% | -- |
| Net Change in Cash | 400.85% | -197.83% | -157.24% | -383.19% | 155.04% |